Anaphylactic Shock – KEGG Pathway

May 19, 2022 Off By admin

Anaphylactic shock (HP:0100845)

KEGG Pathway

Index	Name	P-value	Adjusted p-value	Odds Ratio	Combined score
1	Chronic myeloid leukemia	5.105e-13	3.140e-11	426.86	12081.50
2	Phospholipase D signaling pathway	1.240e-13	1.525e-11	328.47	9761.61
3	Acute myeloid leukemia	9.011e-11	1.232e-9	321.42	7434.41
4	Renal cell carcinoma	1.048e-10	1.289e-9	311.34	7154.30
5	Proteoglycans in cancer	1.254e-12	5.141e-11	233.24	6391.87
6	Natural killer cell mediated cytotoxicity	1.446e-11	2.964e-10	238.38	5949.92
7	B cell receptor signaling pathway	2.384e-10	2.665e-9	262.03	5805.76
8	ErbB signaling pathway	3.049e-10	3.125e-9	248.88	5453.09
9	Ras signaling pathway	3.007e-12	9.246e-11	204.97	5437.89
10	PD-L1 expression and PD-1 checkpoint pathway in cancer	3.855e-10	3.648e-9	236.98	5136.79
11	JAK-STAT signaling pathway	5.260e-11	9.043e-10	190.71	4513.81
12	Endometrial cancer	1.319e-8	9.016e-8	246.12	4465.54
13	T cell receptor signaling pathway	8.515e-10	7.481e-9	200.92	4196.00
14	Pathways in cancer	1.006e-11	2.476e-10	148.89	3770.13
15	Fc epsilon RI signaling pathway	2.527e-8	1.636e-7	207.56	3631.06
16	Neurotrophin signaling pathway	1.686e-9	1.382e-8	174.35	3522.06
17	Central carbon metabolism in cancer	2.843e-8	1.643e-7	201.25	3496.91
18	Prolactin signaling pathway	2.843e-8	1.643e-7	201.25	3496.91
19	Non-small cell lung cancer	3.189e-8	1.705e-7	195.31	3371.33
20	Glioma	3.764e-8	1.929e-7	187.03	3197.34
21	PI3K-Akt signaling pathway	5.881e-11	9.043e-10	132.09	3111.49
22	Insulin signaling pathway	3.435e-9	2.641e-8	150.44	2931.94
23	Colorectal cancer	6.560e-8	3.227e-7	161.85	2677.02
24	Breast cancer	4.901e-9	3.546e-8	139.77	2674.44
25	Prostate cancer	1.067e-7	5.050e-7	142.63	2289.62
26	Choline metabolism in cancer	1.113e-7	5.069e-7	141.11	2259.31
27	Melanogenesis	1.257e-7	5.520e-7	136.72	2172.45
28	C-type lectin receptor signaling pathway	1.414e-7	5.998e-7	132.60	2091.30
29	VEGF signaling pathway	0.000002883	0.000008060	152.56	1946.09
30	Growth hormone synthesis, secretion and action	2.434e-7	9.656e-7	115.22	1754.62
31	GnRH secretion	0.000003690	0.000009868	140.02	1751.57
32	Rap1 signaling pathway	2.938e-8	1.643e-7	96.51	1673.81
33	Relaxin signaling pathway	3.366e-7	0.000001294	105.95	1579.07
34	FoxO signaling pathway	3.580e-7	0.000001335	104.27	1547.61
35	Melanoma	0.000005272	0.00001351	123.73	1503.75
36	Estrogen signaling pathway	4.285e-7	0.000001550	99.53	1459.45
37	Signaling pathways regulating pluripotency of stem cells	5.089e-7	0.000001788	95.21	1379.67
38	Gastric cancer	6.000e-7	0.000002050	91.24	1307.15
39	Thyroid cancer	0.0001485	0.0002646	142.54	1256.48
40	mTOR signaling pathway	6.848e-7	0.000002276	88.18	1251.61
41	Hepatitis C	7.397e-7	0.000002394	86.44	1220.21
42	Hepatitis B	8.386e-7	0.000002645	83.68	1170.81
43	Gap junction	0.000009659	0.00002425	100.36	1158.94
44	Hepatocellular carcinoma	9.698e-7	0.000002982	80.59	1115.92
45	Bladder cancer	0.0001826	0.0003163	127.89	1100.92
46	GnRH signaling pathway	0.00001141	0.00002751	94.76	1078.51
47	MAPK signaling pathway	1.574e-7	6.453e-7	68.17	1067.84
48	Axon guidance	0.000001335	0.000004005	74.20	1003.71
49	Hematopoietic cell lineage	0.00001377	0.00003256	88.81	994.11
50	AGE-RAGE signaling pathway in diabetic complications	0.00001419	0.00003257	87.89	981.15
51	Longevity regulating pathway	0.00001506	0.00003367	86.11	956.11
52	Chemokine signaling pathway	0.000001652	0.000004839	70.22	934.86
53	Viral carcinogenesis	0.000002063	0.000005901	66.30	867.98
54	Cholinergic synapse	0.00002047	0.00004497	77.45	836.23
55	Sphingolipid signaling pathway	0.00002391	0.00005159	73.43	781.36
56	Thyroid hormone signaling pathway	0.00002513	0.00005329	72.17	764.43
57	Human cytomegalovirus infection	0.000003106	0.000008489	59.63	756.31
58	Chemical carcinogenesis	0.000003947	0.00001033	56.04	697.32
59	Long-term depression	0.0003921	0.0006699	85.91	673.90
60	Autophagy	0.00003643	0.00007594	63.51	649.04
61	Apoptosis	0.00004054	0.00008311	61.21	618.98
62	Long-term potentiation	0.0004889	0.0008238	76.63	584.21
63	Mitophagy	0.0005036	0.0008371	75.47	573.09
64	Cellular senescence	0.00005366	0.0001082	55.57	546.37
65	MicroRNAs in cancer	0.00001104	0.00002717	42.88	489.47
66	Bacterial invasion of epithelial cells	0.0006453	0.001058	66.38	487.64
67	Human papillomavirus infection	0.00001430	0.00003257	40.09	447.19
68	Alcoholism	0.00009052	0.0001796	46.39	431.86
69	Kaposi sarcoma-associated herpesvirus infection	0.0001010	0.0001972	44.66	410.90
70	Focal adhesion	0.0001139	0.0002189	42.84	388.99
71	Human immunodeficiency virus 1 infection	0.0001334	0.0002524	40.56	361.91
72	Lipid and atherosclerosis	0.0001390	0.0002591	39.98	355.07
73	Regulation of actin cytoskeleton	0.0001449	0.0002646	39.42	348.45
74	Human T-cell leukemia virus 1 infection	0.0001468	0.0002646	39.23	346.29
75	Thermogenesis	0.0001741	0.0003059	36.98	320.12
76	Insulin resistance	0.001264	0.002019	46.90	312.97
77	Serotonergic synapse	0.001382	0.002180	44.77	294.78
78	Leukocyte transendothelial migration	0.001407	0.002190	44.37	291.36
79	Osteoclast differentiation	0.001741	0.002677	39.73	252.41
80	Aldosterone-regulated sodium reabsorption	0.01835	0.02655	61.59	246.23
81	Apelin signaling pathway	0.002022	0.003070	36.77	228.10
82	Oxytocin signaling pathway	0.002545	0.003818	32.63	194.90
83	Type II diabetes mellitus	0.02277	0.03219	49.25	186.27
84	Carbohydrate digestion and absorption	0.02326	0.03251	48.17	181.19
85	Alzheimer disease	0.0006789	0.001099	22.98	167.63
86	Regulation of lipolysis in adipocytes	0.02717	0.03713	41.02	147.91
87	Pathogenic Escherichia coli infection	0.004124	0.006111	25.38	139.35
88	Adipocytokine signaling pathway	0.03398	0.04592	32.55	110.09
89	Epithelial cell signaling in Helicobacter pylori infection	0.03446	0.04607	32.08	108.04
90	Adherens junction	0.03495	0.04622	31.62	106.05
91	Endocytosis	0.006657	0.009748	19.74	98.94
92	Pancreatic cancer	0.03736	0.04889	29.50	96.98
93	Leishmaniasis	0.03785	0.04900	29.11	95.32
94	Small cell lung cancer	0.04507	0.05774	24.30	75.31
95	Fc gamma R-mediated phagocytosis	0.04747	0.05957	23.03	70.18
96	Phosphatidylinositol signaling system	0.04747	0.05957	23.03	70.18
97	Inflammatory mediator regulation of TRP channels	0.04794	0.05957	22.79	69.22
98	Progesterone-mediated oocyte maturation	0.04890	0.06012	22.32	67.37
99	Amoebiasis	0.04986	0.06012	21.88	65.61
100	Chagas disease	0.04986	0.06012	21.88	65.61
101	Toll-like receptor signaling pathway	0.05081	0.06068	21.45	63.92
102	HIF-1 signaling pathway	0.05319	0.06291	20.45	60.01
103	TNF signaling pathway	0.05462	0.06399	19.90	57.85
104	AMPK signaling pathway	0.05842	0.06779	18.55	52.69
105	Platelet activation	0.06031	0.06933	17.95	50.40
106	Yersinia infection	0.06644	0.07519	16.22	43.98
107	Fluid shear stress and atherosclerosis	0.06738	0.07519	15.98	43.11
108	Measles	0.06738	0.07519	15.98	43.11
109	Ubiquitin mediated proteolysis	0.06785	0.07519	15.87	42.69
110	Spinocerebellar ataxia	0.06926	0.07606	15.53	41.47
111	Pathways of neurodegeneration	0.02233	0.03193	10.32	39.22
112	Non-alcoholic fatty liver disease	0.07487	0.08149	14.31	37.10
113	Herpes simplex virus 1 infection	0.02439	0.03371	9.83	36.49
114	Influenza A	0.08276	0.08930	12.88	32.09
115	Neutrophil extracellular trap formation	0.09060	0.09690	11.70	28.10
116	Epstein-Barr virus infection	0.09655	0.1020	10.94	25.57
117	Diabetic cardiomyopathy	0.09701	0.1020	10.88	25.39
118	cAMP signaling pathway	0.1029	0.1073	10.22	23.24
119	Coronavirus disease	0.1102	0.1139	9.50	20.97
120	Shigellosis	0.1164	0.1193	8.95	19.26
121	Salmonella infection	0.1178	0.1197	8.84	18.92
122	Prion disease	0.1284	0.1295	8.05	16.53
123	Cytokine-cytokine receptor interaction	0.1381	0.1381	7.44	14.74

Categoryautoimmunity

Long COVID-Autoimmunity – Anaphylactic Shock

Anaphylactic shock -GO